Status: current, Not sufficiently defined by necessary conditions definition status. Date: 20-Feb 2019. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
112368601000001116 | Ursodeoxycholic acid 250mg/5ml oral suspension sugar free (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
112368701000001114 | Ursodeoxycholic acid 250mg/5ml oral suspension sugar free | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Ursodeoxycholic acid 250mg/5ml suspension sugar free 250 ml | Has VMP | True | Ursodeoxycholic acid 250mg/5ml oral suspension sugar free | Inferred relationship | Existential restriction modifier | |
Ursofalk 250mg/5ml oral suspension (Sigma Pharmaceuticals Plc) | Is a | True | Ursodeoxycholic acid 250mg/5ml oral suspension sugar free | Inferred relationship | Existential restriction modifier | |
Ursofalk 250mg/5ml suspension (Dr Falk Pharma UK Ltd) | Is a | True | Ursodeoxycholic acid 250mg/5ml oral suspension sugar free | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets